AMAG Pharmaceuticals Inc.


Cantor Remains Sidelined on AMAG Pharmaceuticals, Inc. (AMAG) Following Makena FDA Approval; Here’s Why

In a research report released Thursday, Cantor analyst William Tanner reiterated a Neutral rating on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) with a $17 …

3 Reasons to Buy Palatin Technologies, Inc. (PTN)

Palatin Technologies, Inc. (NYSEMKT:PTN) is circling up to be one of the market’s most undervalued and underestimated stocks this year, and could very …

AMAG Pharmaceuticals, Inc. (AMAG): Makena Autoinjector Key to Stock Performance in 2017

Cantor analyst William Tanner remains sidelined on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) amid their nearly 36% crash yesterday.

Monday’s Healthcare News: AMAG Pharmaceuticals, Inc. (AMAG), Galena Biopharma Inc (GALE), Ariad Pharmaceuticals, Inc. (ARIA)

Today’s healthcare sector offered a great deal of rumble and tumble with the following volatile stocks making headlines today: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts